Risk of cognitive impairment with non-vitamin K antagonist oral anticoagulants in atrial fibrillation: Protocol for a systemic review of randomized controlled trials and real-world studies

Medicine
Long ShenJun Pu

Abstract

The association between use of non-vitamin K antagonist oral anticoagulants (NOACs) with cognitive impairment in atrial fibrillation (AF) remains unknown. An electronic search of Medline, Embase, Cochrane Library databases and ClinicalTrials.gov Website will be performed for randomized controlled trials (RCTs) that reported cognitive impairment events and observational nationwide database studies that reported adjusted hazard ratio (HR) in AF patients with NOACs. The primacy outcome will be a composite of any forms of cognitive impairment. HRs and their 95% confidence intervals (95% CI) will be calculated by using fixed- and random-effects models. Subgroup analyses will be undertaken based on individual NOACs, study types and follow-up duration. This study will provide evidence of the association between use of NOACs and risk of cognitive impairment in patients with AF by pooling the results of RCTs and real-world studies. The results will bring about vigorous evidence in this topic and provide optimal anticoagulation strategy in AF patients at high risk of cognitive disorder. Ethical approval is not applicable for this study. CRD42018103849.

References

Feb 1, 1997·Stroke; a Journal of Cerebral Circulation·A OttA Hofman
Nov 14, 1997·Drugs & Aging·S KonnoK F Mortel
Jul 12, 2002·Statistics in Medicine·Julian P T Higgins, Simon G Thompson
Feb 4, 2010·Heart Rhythm : the Official Journal of the Heart Rhythm Society·T Jared BunchJohn D Day
Jun 7, 2013·Neurology·Evan L ThackerSusan R Heckbert
Aug 12, 2014·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Victoria JacobsT Jared Bunch
Mar 31, 2015·American Heart Journal·Dawn S HuiRichard Lee
Apr 8, 2015·Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association·Tsukasa SaitoNaoyuki Hasebe
Sep 22, 2015·JAMA Neurology·Renée F A G de BruijnM Arfan Ikram
Sep 24, 2015·Stroke; a Journal of Cerebral Circulation·Anna PoggesiLeonardo Pantoni
Jan 21, 2016·Stroke; a Journal of Cerebral Circulation·Hooman KamelCostantino Iadecola
Jan 28, 2016·Circulation. Cardiovascular Quality and Outcomes·Robert J RomanelliKathleen B Orrico
Jan 1, 2017·Revista Española De Cardiología·Paulus KirchhofPanagiotis Vardas
Apr 8, 2017·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Joanna DietzelMatthias Endres
Nov 29, 2017·Expert Review of Cardiovascular Therapy·Victoria JacobsThomas J Bunch
Jan 14, 2018·Mayo Clinic Proceedings·Malini MadhavanAlanna M Chamberlain
Jan 15, 2018·Journal of Alzheimer's Disease : JAD·Daniele PastoriGregory Y H Lip

❮ Previous
Next ❯

Citations

Apr 6, 2019·Frontiers in Neurology·Ludovico AlisiMarco Fiorelli

❮ Previous
Next ❯

Software Mentioned

STATA

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.